Cyclophosphamide is manufactured by several pharmaceutical companies. In the United States, common manufacturers include Fresenius Kabi, Teva Pharmaceuticals, and Pfizer [1][2]. Cyclophosphamide is available in both injectable and oral formulations [3].
How is Cyclophosphamide administered to patients?
Cyclophosphamide can be given intravenously or orally [3]. The method of administration depends on the specific medical condition being treated and the prescribed dosage [4].
What conditions is Cyclophosphamide used to treat?
Cyclophosphamide is used to treat a variety of cancers, including breast cancer, ovarian cancer, non-Hodgkin lymphoma, chronic lymphocytic leukemia, and neuroblastoma [4][5]. It is also used in the treatment of nephrotic syndrome in children and to suppress the immune system in certain autoimmune diseases, such as lupus and rheumatoid arthritis, when other treatments have not been effective [4][6].
What is the mechanism of action for Cyclophosphamide?
Cyclophosphamide is an alkylating agent. It works by damaging the DNA of cancer cells, which stops them from growing and dividing [4][7]. This mechanism also affects rapidly dividing cells of the immune system, which is why it is used in immunosuppression [6].
When does Cyclophosphamide patent exclusivity expire?
The original patents for cyclophosphamide have long since expired. However, newer patents may cover specific formulations, manufacturing processes, or uses. Information on patent expiry for specific cyclophosphamide products can be found on DrugPatentWatch.com [8].
Are there generic versions of Cyclophosphamide available?
Yes, generic versions of cyclophosphamide are available from multiple manufacturers, contributing to its accessibility for patients [1][2].
What are the potential side effects of Cyclophosphamide?
Common side effects of cyclophosphamide include nausea, vomiting, hair loss, and fatigue [5]. More serious side effects can include a reduced ability of the bone marrow to produce blood cells (leading to increased risk of infection, anemia, and bleeding), infertility, and an increased risk of developing other cancers later in life [5][7]. It can also cause bladder irritation, and patients are often advised to drink plenty of fluids [4].
How does Cyclophosphamide compare to other chemotherapy drugs?
Cyclophosphamide belongs to the class of alkylating agents. Other chemotherapy drugs may work through different mechanisms, such as antimetabolites, antimitotics, or topoisomerase inhibitors [7]. The choice of chemotherapy drug depends on the specific type and stage of cancer or autoimmune condition being treated.
Where can I find more information about Cyclophosphamide patents and manufacturers?
Detailed information regarding patents, exclusivity periods, and a comprehensive list of manufacturers for cyclophosphamide can be accessed through DrugPatentWatch.com [8].
Sources:
[1] https://www.drugpatentwatch.com/drugs/cyclophosphamide/manufacturers
[2] https://www.drugpatentwatch.com/drugs/cyclophosphamide/us-generic-manufacturers
[3] https://www.drugpatentwatch.com/drugs/cyclophosphamide/formulations
[4] https://www.nhs.uk/medicines/cyclophosphamide/
[5] https://www.cancer.org/treatment/treatments-and-side-effects/treatment-types/chemotherapy/cyclophosphamide.html
[6] https://www.arthritis.org/health-search/cyclophosphamide-for-rheumatoid-arthritis
[7] https://www.cancer.gov/about-cancer/treatment/drugs/cyclophosphamide
[8] https://www.drugpatentwatch.com/